Sexually transmitted diseases in injection drug users.
The recommended work up for diagnosis of STDs in injection drug users is presented in the box. Diagnostic work up for sexually transmitted disease in injection drug users Asymptomatic patients-screening work up Serology VDRL, HIV antibody, hepatitis B surface antigen, hepatitis C antibodies AND Endocervical specimen Gonococcal culture, gonococcal DNA detection (probe) OR Amplification (PCR), chlamydial DNA detection or amplification OR Urine specimen-gonococcal and chlamydial DNA amplification (PCR) AND Vaginal specimen pH, clue cells, Trichomonas Endourethral specimen Gonococcal DNA amplification, chlamydial DNA amplification OR Urine specimen-gonococcal and chlamydial amplification Symptomatic patients-diagnostic work up All the above AND Genital ulcers Dark-field microscopy, Herpes simplex virus-DNA detection or culture, and, depending on geographic risk factors, Gram's stain for Hemophilus duceryl Exophytic lesions Clinical diagnosis of genital warts, skin biopsy if treatment fails VDRL, Venereal Disease Research Laboratory; PCR, polymerase chain reaction.
Kanno
Mettassebia B
MB
Division of Infectious Diseases, Detroit Medical Center, Wayne State University, 3990 John R, Suite 4YC, Detroit, MI 48201, USA.
Zenilman
Jonathan
J
D000328:Adult; D005260:Female; D006801:Humans; D008297:Male; D015995:Prevalence; D012307:Risk Factors; D015231:Sexually Transmitted Diseases, Bacterial / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology; D015229:Sexually Transmitted Diseases, Viral / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology; D015819:Substance Abuse, Intravenous / Q000150:complications* / Q000453:epidemiology; D014481:United States / Q000453:epidemiology